$LSTA · Stock Market Mentor · 2026-11-09
LSTA 现在值得买入：那根放量红柱并非派发，而是约 4500 万股、价格约 13.12 美元的二次发行，且很快被市场消化，因此撇开这一点，该股正在突破；可以建立初始仓位，止损设在 1320 附近，持有至跌破今日盘中低点为止。相对强度评级为 98，其行业组在 145 个行业中排名第七，每股收益和销售额均快速增长。
逐段跳播
第一个是 Live Stance。注意，他们的财报要到2月底才发布。他们上周才刚公布过财报。股价先是大幅下跌，然后又涨了回来。
The first is Live Stance. Note that their earnings report is not due until the end of February. It reported just last week. The share price first fell a lot, then rose again.
我第一次看到这根K线时，以为这是一个大幅派发的日子。看，成交量多大。当时我并不确定。但后来我又仔细看了看，首先那天是周四。除了反向ETF，周四还有什么没跌？整个市场都承受着很大的抛售压力，但周五有所回升，今天又回升了一些。
when I first saw this bar, I thought it was a big distribution day. Look, what a huge volume. I wasn't sure about this. But then I looked at it a little more carefully, first of all it was Thursday.
Apart from inverse ETFs, what else didn't fall on Thursday? The entire market was under a lot of selling pressure, but it recovered somewhat on Friday and has done so again today.
看今天的成交量，看起来他们做了一次增发。具体细节我记不太清了。其实并不是。这个我在报告里写了，报告是我发给付费会员的。
Looking at today's volume, it looks like they had a secondary offering. I can't remember the details exactly. Actually, it's not. I have this in our report, which I send to premium members.
我说过，如果忽略这根红色K线，因为我们知道它是什么，这只股票就是在突破。如果忽略这个，我们就会看到这只股票实际上正在突破。而在这里，建一个初始仓位、止损设在1320附近是可行的。
好吗？目前这里的最低限价是1320。我今天早些时候在价格稍低时发布了这个，但思路是只要这只股票不跌破今天的盘中低点，就一直做多。
I said that if we ignore this red bar, because we know what it was, the stock is breakout. If we ignore this, we will see that the stock is actually breaking out. And here a starting position would work with a stop loss around 1320.
Okay? Currently, the minimum limit here is 1320. I published this earlier today when it was a little lower, but the idea is to stay long on this stock until it breaks below today's intraday low.
现在的数据是这样的。它的相对强度评级是98。换句话说，它远远领先于98%的上市公司。它所属的医疗保健板块在145个行业中排名第七。所以这相当不错。每股收益和销售额都在快速增长。
而且他们以约13.12美元的价格增发了4500万股。这个价格非常低。显然那些股票很快就被买光了。流动性大幅增加，达到约1400万股。或者其实是4500万股。所以这只股票现在正在做它本不该做的事。然而由于增发，它在这里出现了巨大的成交量。
Now the statistics are like this. Its relative strength rating is 98. In other words, it is far ahead of 98% of publicly traded stocks. The healthcare sector, the industry group to which it belongs, ranks seventh out of 145.
So that's pretty good. Earnings per share and sales are growing rapidly. And they had a secondary offering of 45 million shares at about $13.12. That is very low. Obviously those shares were bought up quickly.
Liquidity had increased significantly, to about 14 million shares. Or actually 45 million shares. So this stock is doing what it's not supposed to do now. Yet it is here in huge volume due to secondary offerings.
所以我认为这是一只你现在就可以看看并买入的股票。我再说一遍，收益计算或者说财报已经结束了。这和Nvidia没有任何关系。总之，这会很有意思。所以我认为你可以投资这只股票。
So I think this is a stock you can look at and buy right now. I repeat, the income calculation or earnings is over. This has nothing to do with Nvidia. Anyway, that's going to be fun. So I think you can invest in this stock.